MetALD patients were more frequently delisted due to clinical deterioration than ALD patients, although the difference did not reach statistical significance (85.7% vs. 41.7%, p =0.083) (Table 3 ).
← all excerpts
Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation.
1
0.0830
0.0830